DISCUSSION:
1: Economic Viability Policy Analysis
Healthcare organizations must be economically viable to implement and maintain policies. Cost-benefit analysis measures viability and highlights when or where changes need to be made to ensure financial sustainability. In a minimum of 250 words, discuss the following:
• Find a healthcare company (department or company-wide) of your choosing and examine the financial policy within that company that supports or negates sustainability (i.e., cost, benefit, and outcome). Provide a rationale for your position.
2: Process of Value Analysis
Assessing value in health care is based on outcome. The policy that is implemented to analyze value must be one that is specific to the healthcare organization, and must address the value issues (i.e., past, current, and forecasted). It is important to note that ethics and values are both inclusive and exclusive of each other in terms of policy; from both the stance of "professional decision-making" and "policy analysis."
In a minimum of 250 words, discuss the following:
• Review the "General Requirements for Informed Consent".
• Create an Informed Consent (for a hypothetical human subject research) using items 1 - 8 under Section A.
Assignment: Implementation of Strategy
Healthcare organizations require astute handling of strategy implementation. The processes must be followed with a contingency plan in place for failed strategic objectives leading to the goal.
• Review the stages of implementation in Chapter .
• Review "340B Drug Pricing Program Oversight" case in your textbook .
• Provide a written analysis of the implementation phases that were used/excluded in the "340B Drug Pricing Program Oversight" case.
• Explain what the literature (external scholarly source) suggest(s) regarding health implementation strategy regarding drug pricing.
• Conclude with a summary of your research.
Your paper:
• Must be 4 to 6 double-spaced pages in length (not including title and reference pages) and formatted according to APA style as outlined in the Ashford Writing Center.
• Must use at least four scholarly sources in addition to the course text.
• Must document all sources in APA style as outlined in the Ashford Writing Center.
• Must include a separate reference page that is formatted according to APA style as outlined in the Ashford Writing Center.
Required Resource:
Text:
1. McLaughlin, C. P., & McLaughlin, C. D. (2014). Health Policy Analysis: An interdisciplinary approach (2nd ed.).
a. Chapter : The Policy Analysis Process: Evaluation of Economic Viability
b. Chapter : The Policy Analysis Process: Analysis of Values
c. Chapter: Implementation Strategy and Planning
Textbook:
1. Rychlik, R. (2002). Strategies in pharmacoeconomics and outcomes research. Binghamton, NY: Pharmaceutical Products Press/Haworth Press.
o The text provides an analysis of the strategies used to analyze the economic viability of the pharmaceutical industry (a major healthcare sector). The book outlines the impact of health economic polic(ies) relating to pharmaceutical research and development, sales and marketing, and special interest groups; all important components of health policy.
Article
1. Nord, E., Daniels, N., &Kamlet, M. (2009). QALYs: Some challenges. Value in Health
o Quality adjusted life-year (QALY) is used as a measure of health quality. QALY is used to determine when and where healthcare resources need to be allocated to ensure quality outcomes. The authors reviewed challenges they deemed as important that is faced when QALY is used as a health policy decision-making tool.